TCTR20210325003尚未招募不适用
Immunogenicity of COVID-19 vaccines in King Chulalongkorn Memorial hospital health care workers
Ratchadapiseksompotch Research Fund0 个研究点目标入组 1 人开始时间: 2021年3月25日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1.The subject is aged > 18 years
- •2.Subjects had no history of COVID-19 vaccination before enrollment
- •3.Subjects who can comply with trial procedures and are available for the duration of follow-up
排除标准
- •1.Subjects who received any other vaccines within 1 month prior to enrollment
- •2.Subjects who received blood or blood product or immunoglobulin within 3 months prior to enrollment
- •3.Subjects participating in any clinical trial with COVID-19 immunogenicity
研究者
相似试验
尚未招募
不适用
Immunogenicity and safety COVID-19 vaccine in healthy adults: a single institute based cohort studyCOVID-19JPRN-UMIN000043589Saga University60
进行中（未招募）
1 期
Immune response of COVID-19 vaccines in medical staff and special risk populationsEUCTR2021-001512-28-DECharité - Universitätsmedizin Berlin3,050
招募中
2 期
Safety and immunogenicity of Q fever vaccine in children aged 10 to 15 years.Q feverACTRN12617000375358The Children's Hospital at Westmead20
进行中（未招募）
不适用
Immunogenicity and safety of COVID-19 vaccines in SLE and rheumatoid arthritis patientsSLERAImmunosuppresive agentsImmunogenicity to SARS-CoV2 vaccinationSLEImmunosuppressive therapyHumoral immune responseCellular immune responseSARS-CoV-2 vaccineRATCTR20210917003Ratchadapiseksompotch Fund, Faculty of Medicine100
已完成
1 期
Safety and Immunogenicity of EXG-5003.Prevention for SARS-CoV-2 infection diseaseJPRN-jRCT2041210013Doi Yohei60